共 50 条
- [31] Neoadjuvant nivolumab, gemcitabine and cisplatin in muscle-invasive bladder cancer: Study updateCANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)Gupta, ShilpaWeight, Christopher J.Agarwal, NeerajGupta, SumatiKonety, BadrinathGibb, EwanDavicioni, ElaiThyagarajan, BharatSonpavde, Guru
- [32] Methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and cystectomy for unresectable bladder cancerJOURNAL OF UROLOGY, 1996, 156 (02): : 368 - 371Donat, SMHerr, HWBajorin, DFFair, WRSogani, PCRusso, PSheinfeld, JScher, HI
- [33] Safety and efficacy of neoadjuvant chemotherapy (NAC) with accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (aMVAC) in patients (pts) with muscle invasive bladder cancer (MIBC) as a function of ageJOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)Zibelman, Matthew R.Lewis, BiancaRoss, Eric A.Anari, FernGhatalia, PoojaPlimack, Elizabeth R.Geynisman, Daniel M.
- [35] Neoadjuvant Immunotherapy for Muscle-Invasive Bladder CancerMEDICINA-LITHUANIA, 2021, 57 (08):Peyrottes, ArthurOuzaid, IdirCalifano, GianluigiHermieu, Jean-FrancoisXylinas, Evanguelos
- [36] Neoadjuvant therapy for muscle-invasive bladder cancerEXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (07) : 603 - 614Jain, Rohit K.Sonpavde, Guru
- [37] METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN FOLLOWED BY RADIOTHERAPY OR SURGERY FOR MUSCLE INVASIVE BLADDER-CANCER - THE UNIVERSITY-OF-CHICAGO EXPERIENCEJOURNAL OF UROLOGY, 1993, 149 (04): : 753 - 757VOGELZANG, NJMOORMEIER, JAAWAN, AMWEICHSELBAUM, RRFARAH, RSTRAUS, FHSCHOENBERG, HWCHODAK, GW
- [38] The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancerJOURNAL OF UROLOGY, 2000, 163 (05): : 1413 - 1418Ennis, RDPetrylak, DPSingh, PBagiella, EO'Toole, KMBenson, MCOlsson, CA
- [39] A phase II study investigating neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive bladder cancer: Final analysisANNALS OF ONCOLOGY, 2020, 31 : S1319 - S1319Szabados, B. E.Rodriguez-Vida, A.Duran, I.Crabb, S. J.van der Heijden, M. S.Pous, A. FontGravis, G.Herranz, U. AnidoProtheroe, A.Ravaud, A.Maillet, D.Mendez, M. J.Suarez, C.Linch, M.Prendergast, A.Tyson, C.Mousa, K.Castellano, D.Powles, T. B.
- [40] Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II TrialJOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (12) : 1312 - +Funt, Samuel A.Lattanzi, MichaelWhiting, KarissaAl-Ahmadie, HikmatQuinlan, ColleenTeo, Min YuenLee, Chung-HanAggen, DavidZimmerman, DanielleMcHugh, DeaglanApollo, ArlynDurdin, Trey D.Truong, HongKamradt, JeffreyKhalil, MagedLash, BradleyOstrovnaya, IrinaMcCoy, Asia S.Hettich, GraceRegazzi, AshleyJihad, MarwahRatna, NehaBoswell, AbigailFrancese, KaitlynYang, YuanquanFolefac, EdmundHerr, Harry W.Donat, S. MachelePietzak, EugeneCha, Eugene K.Donahue, Timothy F.Goh, Alvin C.Huang, William C.Bajorin, Dean F.Iyer, GopaBochner, Bernard H.Balar, Arjun V.Mortazavi, AmirRosenberg, Jonathan E.